Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 2
1987 1
1989 1
1990 5
1992 4
1994 7
1995 11
1996 16
1997 15
1998 24
1999 21
2000 17
2001 25
2002 26
2003 23
2004 22
2005 26
2006 34
2007 23
2008 23
2009 3
2010 3
2011 3
2012 4
2013 7
2014 7
2015 4
2016 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

347 results
Results by year
Filters applied: . Clear all
Page 1
Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).
Sikov WM, Berry DA, Perou CM, Singh B, Cirrincione CT, Tolaney SM, Kuzma CS, Pluard TJ, Somlo G, Port ER, Golshan M, Bellon JR, Collyar D, Hahn OM, Carey LA, Hudis CA, Winer EP. Sikov WM, et al. J Clin Oncol. 2015 Jan 1;33(1):13-21. doi: 10.1200/JCO.2014.57.0572. Epub 2014 Aug 4. J Clin Oncol. 2015. PMID: 25092775 Free PMC article. Clinical Trial.
Age and acute myeloid leukemia.
Appelbaum FR, Gundacker H, Head DR, Slovak ML, Willman CL, Godwin JE, Anderson JE, Petersdorf SH. Appelbaum FR, et al. Blood. 2006 May 1;107(9):3481-5. doi: 10.1182/blood-2005-09-3724. Epub 2006 Feb 2. Blood. 2006. PMID: 16455952 Free PMC article. Clinical Trial.
347 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page